Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Recher

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Blood|October 31, 2008
Hematopoietic cell-derived interferon controls viral replication and virus-induced diseasePhilipp A Lang, Luisa Cervantes-Barragan, Admar Verschoor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2022
Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiencyJulia R Hirsiger, Sebastian Weigang, Antje-Christine Walz, et al.
Journal of Autoimmunity|August 17, 2021
Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccinationJulia R Hirsiger, Giorgio Tamborrini, Dorothee Harder, et al.
Contemporary Clinical Trials Communications|October 20, 2022
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trialMáté Krausz, Annette Uhlmann, Ina Caroline Rump, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 16, 2019
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor TreatmentStefan Diem, Mirjam Fässler, David Bomze, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHCMarianne M Martinic, Maries F van den Broek, Thomas Rülicke, et al.
The Journal of Experimental Medicine|December 7, 2011
Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombinationDuane R Wesemann, Jennifer M Magee, Cristian Boboila, et al.
Frontiers in Immunology|March 5, 2025
Recognition of MR1-antigen complexes by TCR Vγ9Vδ2José Pedro Loureiro, Alessandro Vacchini, Giuliano Berloffa, et al.
Journal of Clinical Immunology|October 29, 2022
CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling ResponsesVioleta Block, Eirini Sevdali, Mike Recher, et al.
Nature Cell Biology|March 14, 2026
An SP110-SP100 axis is a critical regulator of promyelocytic leukaemia body dynamics and mitotic fidelityEric J Aird, Julius Rabl, Tabea Knuesel, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Blood|October 31, 2008
Hematopoietic cell-derived interferon controls viral replication and virus-induced diseasePhilipp A Lang, Luisa Cervantes-Barragan, Admar Verschoor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2022
Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiencyJulia R Hirsiger, Sebastian Weigang, Antje-Christine Walz, et al.
Journal of Autoimmunity|August 17, 2021
Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccinationJulia R Hirsiger, Giorgio Tamborrini, Dorothee Harder, et al.
Contemporary Clinical Trials Communications|October 20, 2022
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trialMáté Krausz, Annette Uhlmann, Ina Caroline Rump, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 16, 2019
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor TreatmentStefan Diem, Mirjam Fässler, David Bomze, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHCMarianne M Martinic, Maries F van den Broek, Thomas Rülicke, et al.
The Journal of Experimental Medicine|December 7, 2011
Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombinationDuane R Wesemann, Jennifer M Magee, Cristian Boboila, et al.
Frontiers in Immunology|March 5, 2025
Recognition of MR1-antigen complexes by TCR Vγ9Vδ2José Pedro Loureiro, Alessandro Vacchini, Giuliano Berloffa, et al.
Journal of Clinical Immunology|October 29, 2022
CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling ResponsesVioleta Block, Eirini Sevdali, Mike Recher, et al.
Nature Cell Biology|March 14, 2026
An SP110-SP100 axis is a critical regulator of promyelocytic leukaemia body dynamics and mitotic fidelityEric J Aird, Julius Rabl, Tabea Knuesel, et al.
Pageof 13